Skip to content

Insider · CIK 0002089248

David Spencer Soffer

director

Files at XBIT (XBiotech Inc.). First filing -, latest -.

David Spencer Soffer files SEC Form 4 as director at XBIT (XBiotech Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; David Spencer Soffer has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 1 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2025XBIT
XBiotech Inc.
AGrant or award
Director Stock Optionderivative
+51,000$0.00$051,000Nov 12, 2025

Questions about David Spencer Soffer

Answered from the filings on this page, as of the latest one.

Is David Spencer Soffer buying or selling?

David Spencer Soffer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did David Spencer Soffer's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Spencer Soffer has 0.

Where does David Spencer Soffer file Form 4?

David Spencer Soffer has filed Form 4 at XBIT (XBiotech Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David Spencer Soffer: insider trades and track record | InsiderTell